Carlo Bello is an experienced Executive Director at Pfizer, leading the global development team for the ARV-471 breast cancer program in collaboration with Arvinas Inc. Since joining Pfizer in January 2004, Carlo has held various roles, including Senior Director and Clinical Pharmacologist in Oncology and Pediatric Drug Development, as well as working to enhance clinical trial capacity at the Infectious Disease Institute as a Global Health Fellow. Prior to Pfizer, Carlo served as a Clinical Pharmacology Specialist at Sugen, Inc., contributing to oncology development. Carlo holds a Bachelor of Science degree in Biology from the University of California, San Francisco, and also attended the University of San Francisco.
This person is not in any teams
This person is not in any offices